Trials / Active Not Recruiting
Active Not RecruitingNCT05888844
A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma
A Phase 2 Study Evaluating INCB099280 in Participants With Advanced Squamous Cell Carcinoma
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Incyte Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being conducted to determine the safety, tolerability, and preliminary efficacy of INCB099280 in participants with advanced Cutaneous Squamous Cell Carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | INCB099280 | Administered as specified in the treatment arm description. |
Timeline
- Start date
- 2023-10-09
- Primary completion
- 2026-09-28
- Completion
- 2026-09-28
- First posted
- 2023-06-05
- Last updated
- 2026-02-24
Locations
77 sites across 15 countries: Australia, Brazil, Canada, Chile, Croatia, France, Hungary, Montenegro, New Zealand, North Macedonia, Romania, South Africa, South Korea, Spain, Turkey (Türkiye)
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05888844. Inclusion in this directory is not an endorsement.